Find Research outputs

Search results

• A double, long polar fimbria mutant of Escherichia coli O157:H7 expresses curli and exhibits reduced in vivo colonization

  Lloyd, S. J., Ritchie, J. M., Rojas-Lopez, M., Blumentritt, C. A., Popov, V. L., Greenwich, J. L., Waldor, M. K. & Torres, A. G., Mar 2012, In: Infection and immunity. 80, 3, p. 914-920 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Escherichia coli O157
  • Epithelial Cells
  • Enterohemorrhagic Escherichia coli
  • Congo Red
  • Hemolytic-Uremic Syndrome
  33 Scopus citations

• A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei

  Gregory, A. E., Judy, B. M., Qazi, O., Blumentritt, C. A., Brown, K. A., Shaw, A. M., Torres, A. G. & Titball, R. W., Feb 1 2015, In: Nanomedicine: Nanotechnology, Biology, and Medicine. 11, 2, p. 447-456 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Glycoconjugates
  • Burkholderia mallei
  • Gold nanoparticles
  • Vaccines
  • Gold
  53 Scopus citations

• Burkholderia pseudomallei ΔtonB Δhcp1 live attenuated vaccine strain elicits full protective immunity against aerosolized melioidosis infection

  Khakhum, N., Bharaj, P., Myers, J. N., Tapia, D., Kilgore, P. B., Ross, B. N., Walker, D. H., Endsley, J. J. & Torresa, A. G., Jan 1 2019, In: mSphere. 4, 1, e00570-18.

  Research output: Contribution to journal › Article › peer-review

  • Melioidosis
  • Burkholderia pseudomallei
  • Attenuated Vaccines
  • Burkholderia mallei
  • Immunity
  11 Scopus citations

• Characterization of the Burkholderia cenocepacia TonB mutant as a potential live attenuated vaccine

  Pradenas, G. A., Myers, J. N. & Torres, A. G., Dec 2017, In: Vaccines. 5, 4, 33.

  Research output: Contribution to journal › Article › peer-review

  • Burkholderia cenocepacia
  • Attenuated Vaccines
  • Burkholderia Infections
  • Intranasal Administration
  • Gene Deletion
  7 Scopus citations

• Characterization of the Burkholderia mallei tonB mutant and its potential as a backbone strain for vaccine development

  Mott, T. M., Vijayakumar, S., Sbrana, E., Endsley, J. J. & Torres, A. G., Jun 26 2015, In: PLoS neglected tropical diseases. 9, 6, e0003863.

  Research output: Contribution to journal › Article › peer-review

  • Burkholderia mallei
  • Melioidosis
  • Glanders
  • Vaccines
  • Iron
  23 Scopus citations

• Clinical implications of enteroadherent escherichia coli

  Arenas-Hernández, M. M. P., Martínez-Laguna, Y. & Torres, A. G., Oct 2012, In: Current gastroenterology reports. 14, 5, p. 386-394 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Escherichia coli
  • Small Intestine
  • Enteropathogenic Escherichia coli
  • Enterotoxigenic Escherichia coli
  • Microvilli
  21 Scopus citations

• Combating the great mimicker: latest progress in the development of Burkholderia pseudomallei vaccines

  Khakhum, N., Chapartegui-González, I. & Torres, A. G., 2020, In: Expert review of vaccines. p. 1-8 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Burkholderia pseudomallei
  • Melioidosis
  • Vaccines
  • Clinical Trials
  • Glycoconjugates

• Comparative genomics of a subset of Adherent/Invasive Escherichia coli strains isolated from individuals without inflammatory bowel disease

  Barrios-Villa, E., Martínez de la Peña, C. F., Lozano-Zaraín, P., Cevallos, M. A., Torres, C., Torres, A. G. & Rocha-Gracia, R. D. C., Mar 2020, In: Genomics. 112, 2, p. 1813-1820 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Genomics
  • Inflammatory Bowel Diseases
  • Escherichia coli
  • Type II Secretion Systems
  • Single Nucleotide Polymorphism
  4 Scopus citations

• Comparing in vitro and in vivo virulence phenotypes of Burkholderia pseudomallei type G strains

  Lewis, E. R. G., Kilgore, P. B., Mott, T. M., Pradenas, G. A. & Torres, A. G., Apr 2017, In: PloS one. 12, 4, e0175983.

  Research output: Contribution to journal › Article › peer-review

  • Burkholderia pseudomallei
  • Virulence
  • virulence
  • phenotype
  • Phenotype
  3 Scopus citations

• Consensus on the development of vaccines against naturally acquired melioidosis

  Limmathurotsakul, D., Funnell, S. G. P., Torres, A. G., Morici, L. A., Brett, P. J., Dunachie, S., Atkins, T., Altmann, D. M., Bancroft, G. & Peacock, S. J., Jun 1 2015, In: Emerging infectious diseases. 21, 6, p. e1-e7

  Research output: Contribution to journal › Article › peer-review

  • Melioidosis
  • Consensus
  • Vaccines
  • Government Employees
  • Biological Warfare Agents
  31 Scopus citations

• Development of a gold nanoparticle vaccine against enterohemorrhagic escherichia coli o157:H7

  Sanchez-Villamil, J. I., Tapia, D. & Torres, A. G., 2019, In: mBio. 10, 4, e01869-19.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Enterohemorrhagic Escherichia coli
  • Escherichia coli O157
  • Gold
  • Nanoparticles
  • Vaccines
  10 Scopus citations

• Development of a multiplex PCR assay for detection of Shiga toxin-producing Escherichia coli, enterohemorrhagic E. coli, and enteropathogenic E. coli strains.

  Botkin, D. J., Galli, L., Sankarapani, V., Soler, M., Rivas, M. & Torres, A. G., 2012, In: Frontiers in Cellular and Infection Microbiology. 2, p. 8 1 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Enterohemorrhagic Escherichia coli
  • Shiga-Toxigenic Escherichia coli
  • Enteropathogenic Escherichia coli
  • Multiplex Polymerase Chain Reaction
  • Escherichia coli O157
  23 Scopus citations

• Emerging role of biologics for the treatment of melioidosis and glanders

  Tapia, D., Sanchez-Villamil, J. I. & Torres, A. G., Dec 2 2019, In: Expert Opinion on Biological Therapy. 19, 12, p. 1319-1332 14 p.

  Research output: Contribution to journal › Review article › peer-review

  • Glanders
  • Melioidosis
  • Biological Products
  • Burkholderia mallei
  • Burkholderia
  2 Scopus citations

• Enteropathogenic Escherichia coli: Foe or innocent bystander?

  Hu, J. & Torres, A. G., Aug 1 2015, In: Clinical Microbiology and Infection. 21, 8, p. 729-734 6 p.

  Research output: Contribution to journal › Review article › peer-review

  • Enteropathogenic Escherichia coli
  • Diarrhea
  • Genotype
  • Research Personnel
  • Infection
  83 Scopus citations

• Escherichia coli diseases in Latin America-a 'One Health' multidisciplinary approach

  Torres, A. G., Mar 2017, In: Pathogens and disease. 75, 2

  Research output: Contribution to journal › Article › peer-review

  • One Health
  • Latin America
  • Escherichia coli
  • Interdisciplinary Research
  • Escherichia coli Infections
  14 Scopus citations

• Evaluating the role of Burkholderia pseudomallei K96243 toxins BPSS0390, BPSS0395, and BPSS1584 in persistent infection

  Ross, B. N., Micheva-Viteva, S., Hong-Geller, E. & Torres, A. G., Dec 1 2019, In: Cellular Microbiology. 21, 12, e13096.

  Research output: Contribution to journal › Article › peer-review

  • Burkholderia pseudomallei
  • Anti-Bacterial Agents
  • Melioidosis
  • Levofloxacin
  • Infection
  4 Scopus citations

• Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis

  Khakhum, N., Bharaj, P., Myers, J. N., Tapia, D., Walker, D. H., Endsley, J. J. & Torres, A. G., Jul 2019, In: PLoS neglected tropical diseases. 13, 7, e0007578.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Burkholderia mallei
  • Glanders
  • Melioidosis
  • Attenuated Vaccines
  • Humoral Immunity
  5 Scopus citations

• Exploiting the power of OMICS approaches to produce E. Coli O157 vaccines

  Kalita, A., Kalita, M. & Torres, A. G., Jan 26 2015, In: Gut Microbes. 5, 6, p. 770-774 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Escherichia coli Vaccines
  • Escherichia coli O157
  • Enterohemorrhagic Escherichia coli
  • Power (Psychology)
  • Vaccines
  5 Scopus citations

• Extensive identification of bacterial riboflavin transporters and their distribution across bacterial species

  Gutiérrez-Preciado, A., Torres, A. G., Merino, E., Bonomi, H. R., Goldbaum, F. A. & García-Angulo, V. A., May 4 2015, In: PloS one. 10, 5, e0126124.

  Research output: Contribution to journal › Article › peer-review

  • Riboflavin
  • riboflavin
  • transporters
  • Bacteria
  • Flavin Mononucleotide
  49 Scopus citations

• Fimbriation and curliation in escherichia coli O157:H7 a paradigm of intestinal and environmental colonization

  Lloyd, S. J., Ritchie, J. M. & Torres, A. G., 2012, In: Gut Microbes. 3, 3, p. 272-276 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Escherichia coli O157
  • Shiga-Toxigenic Escherichia coli
  • Bacterial Adhesins
  • Rabbits
  • Escherichia coli Infections
  27 Scopus citations

• Finding regulators associated with the expression of the long polar fimbriae in enteropathogenic Escherichia coli

  Hu, J., Ross, B. N., Cieza, R. J. & Torres, A. G., 2015, In: Journal of bacteriology. 197, 23, p. 3658-3665 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Enteropathogenic Escherichia coli
  • Enterohemorrhagic Escherichia coli
  • Histones
  • Caco-2 Cells
  • Mutagenesis
  2 Scopus citations

• Hacking the host: exploitation of macrophage polarization by intracellular bacterial pathogens

  Thiriot, J. D., Martinez-Martinez, Y. B., Endsley, J. J. & Torres, A. G., Feb 1 2020, In: Pathogens and disease. 78, 1

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Macrophages
  • Innate Immunity
  4 Scopus citations

• Identification of coli surface antigen 23, a novel adhesin of enterotoxigenic Escherichia coli

  Del Canto, F., Botkin, D. J., Valenzuela, P., Popov, V., Ruiz-Perez, F., Nataro, J. P., Levine, M. M., Stine, O. C., Pop, M., Torres, A. G. & Vidal, R., Aug 2012, In: Infection and immunity. 80, 8, p. 2791-2801 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Enterotoxigenic Escherichia coli
  • Surface Antigens
  • Escherichia coli Adhesins
  • Fimbriae Proteins
  • Caco-2 Cells
  30 Scopus citations

• Immunomodulation for gastrointestinal infections

  Cieza, R. J., Cao, A. T., Cong, Y. & Torres, A. G., Mar 2012, In: Expert Review of Anti-Infective Therapy. 10, 3, p. 391-400 10 p.

  Research output: Contribution to journal › Review article › peer-review

  • Immunomodulation
  • Regulatory T-Lymphocytes
  • Homeostasis
  • Bacterial Antigens
  • T-Lymphocyte Subsets
  20 Scopus citations

• Imunidade materna, uma forma de conferir proteção contra Escherichia coli enteropatogênica

  Torres, A. G., Nov 2017, In: Jornal de Pediatria. 93, 6, p. 548-550 3 p.

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• Increased mortality in mice following immunoprophylaxis therapy with high dosage of nicotinamide in burkholderia persistent infections

  Micheva-Viteva, S. N., Ross, B. N., Gao, J., Adikari, S., Zhang, P., Mourant, J. R., Wu, T. H., Werner, J. H., Torres, A. G. & Hong-Geller, E., Jan 1 2019, In: Infection and immunity. 87, 1, e00592.

  Research output: Contribution to journal › Article › peer-review

  • Burkholderia Infections
  • Niacinamide
  • Mortality
  • Anti-Bacterial Agents
  • Burkholderia
  3 Scopus citations

• In vivo bioluminescence imaging of Escherichia coli O104:H4 and role of aerobactin during colonization of a mouse model of infection

  Torres, A. G., Cieza, R. J., Rojas-Lopez, M., Blumentritt, C. A., Souza, C. S., Johnston, R. K., Strockbine, N., Kaper, J. B., Sbrana, E. & Popov, V. L., 2012, In: BMC Microbiology. 12, 112.

  Research output: Contribution to journal › Article › peer-review

  • Escherichia coli O104
  • aerobactin
  • aerobactin receptor
  • Iron
  • Infection
  16 Scopus citations

• Melioidosis: The hazards of incomplete peer-review

  Limmathurotsakul, D., Daily, F., Bory, S., Khim, G., Joost Wiersinga, W., Torres, A. G., Dance, D. A. B. & Currie, B. J., 2019, In: PLoS neglected tropical diseases. 13, 3, e0007123.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Melioidosis in Mexico: a Coordinated Effort to Educate the Medical Specialists and the Community About an Unknown Disease Endemic in the Country

  Alvarez-Hernandez, G. & Torres, A. G., Sep 15 2019, In: Current Tropical Medicine Reports. 6, 3, p. 116-119 4 p.

  Research output: Contribution to journal › Review article › peer-review

  • Melioidosis
  • Endemic Diseases
  • Mexico
  • Burkholderia pseudomallei
  • State Government

• Misidentification of Burkholderia pseudomallei and Other Burkholderia Species from Pediatric Infections in Mexico

  Meza-Radilla, G., Mendez-Canarios, A., Xicohtencatl-Cortes, J., Escobedo-Guerra, M. R., Torres, A. G., Antonio Ibarra, J. & Estrada-De Los Santos, P., Feb 2019, In: Open Forum Infectious Diseases. 6, 2

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Burkholderia cepacia complex
  • Burkholderia
  • Burkholderia pseudomallei
  • Mexico
  • Pneumonia
  2 Scopus citations

• Molecular mechanisms that mediate colonization of shiga toxin-producing Escherichia coli strains

  Farfan, M. J. & Torres, A. G., Mar 2012, In: Infection and immunity. 80, 3, p. 903-913 11 p.

  Research output: Contribution to journal › Short survey › peer-review

  • Shiga-Toxigenic Escherichia coli
  • Bacterial Adhesins
  • Host-Pathogen Interactions
  • Escherichia coli Infections
  • Whole Genome Sequencing
  98 Scopus citations

• Multicomponent gold nano-glycoconjugate as a highly immunogenic and protective platform against Burkholderia mallei

  Tapia, D., Sanchez-Villamil, J. I. & Torres, A. G., Dec 1 2020, In: npj Vaccines. 5, 1, 82.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Burkholderia mallei
  • Glycoconjugates
  • Gold
  • Vaccines
  • Antigens

• Multinucleated giant cell formation as a portal to chronic bacterial infections

  Stockton, J. L. & Torres, A. G., Nov 2020, In: Microorganisms. 8, 11, p. 1-10 10 p., 1637.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Giant Cells
  • Bacterial Infections
  • Melioidosis
  • Burkholderia pseudomallei
  • Lenses

• Novel multi-component vaccine approaches for Burkholderia pseudomallei

  Morici, L., Torres, A. G. & Titball, R. W., May 2019, In: Clinical and Experimental Immunology. 196, 2, p. 178-188 11 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Burkholderia pseudomallei
  • Melioidosis
  • Vaccines
  • Bacteria
  • Animal Disease Models
  8 Scopus citations

• Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with burkholderia pseudomallei

  AuCoin, D. P., Reed, D. E., Marlenee, N. L., Bowen, R. A., Thorkildson, P., Judy, B. M., Torres, A. G. & Kozel, T. R., Apr 17 2012, In: PloS one. 7, 4, e35386.

  Research output: Contribution to journal › Article › peer-review

  • Burkholderia pseudomallei
  • Polysaccharides
  • monoclonal antibodies
  • polysaccharides
  • lipopolysaccharides
  30 Scopus citations

• Predicting toxins found in toxin–antitoxin systems with a role in host-induced Burkholderia pseudomallei persistence

  Ross, B. N., Thiriot, J. D., Wilson, S. M. & Torres, A. G., Dec 1 2020, In: Scientific reports. 10, 1, 16923.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Burkholderia pseudomallei
  • Hibernation
  • Melioidosis
  • Macrophages
  • Anti-Bacterial Agents

• Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis

  Judy, B. M., Taylor, K., Deeraksa, A., Johnston, R. K., Endsley, J. J., Vijayakumar, S., Aronson, J. F., Estes, D. M. & Torres, A. G., Mar 20 2012, In: PloS one. 7, 3, e34176.

  Research output: Contribution to journal › Article › peer-review

  • melioidosis
  • oligodeoxyribonucleotides
  • Melioidosis
  • Oligonucleotides
  • Animals
  22 Scopus citations

• Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine

  Torres, A. G., Gregory, A. E., Hatcher, C. L., Vinet-Oliphant, H., Morici, L. A., Titball, R. W. & Roy, C. J., Jan 29 2015, In: Vaccine. 33, 5, p. 686-692 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Glanders
  • glanders
  • nanogold
  • Glycoconjugates
  • glycoconjugates
  40 Scopus citations

• Recent Advances in Burkholderia mallei and B. pseudomallei Research

  Hatcher, C. L., Muruato, L. A. & Torres, A. G., Jun 1 2015, In: Current Tropical Medicine Reports. 2, 2, p. 62-69 8 p.

  Research output: Contribution to journal › Review article › peer-review

  • Burkholderia mallei
  • Burkholderia pseudomallei
  • Glanders
  • Melioidosis
  • Vaccines
  28 Scopus citations

• Recent progress in melioidosis and glanders

  Torres, A. G. & Steinmetz, I., 2012, In: Frontiers in Microbiology. 3, APR

  Research output: Contribution to journal › Article › peer-review
  1 Scopus citations

• The Escherichia coli O157: H7 cattle immunoproteome includes outer membrane protein A (OmpA), a modulator of adherence to bovine rectoanal junction squamous epithelial (RSE) cells

  Kudva, I. T., Krastins, B., Torres, A. G., Griffin, R. W., Sheng, H., Sarracino, D. A., Hovde, C. J., Calderwood, S. B. & John, M., Jun 1 2015, In: Proteomics. 15, 11, p. 1829-1842 14 p.

  Research output: Contribution to journal › Article › peer-review

  • OMPA outer membrane proteins
  • Epithelial Cells
  • Escherichia coli O157
  • Escherichia coli
  • Modulators
  12 Scopus citations

• The IbeA invasin of adherent-invasive Escherichia coli mediates nteraction with intestinal epithelia and macrophages

  Cieza, R. J., Hu, J., Ross, B. N., Sbrana, E. & Torres, A. G., 2015, In: Infection and immunity. 83, 5, p. 1904-1918 15 p.

  Research output: Contribution to journal › Article › peer-review

  • Intestinal Mucosa
  • Macrophages
  • Escherichia coli
  • Transcytosis
  • Cecum
  28 Scopus citations

• The Importance of International Collaborations to Advance Research Endeavors

  Torres, A. G., Jan 2017, In: PLoS pathogens. 13, 1, e1006047.

  Research output: Contribution to journal › Comment/debate › peer-review
  1 Scopus citations

• The role of long polar fimbriae in Escherichia coli O104:H4 adhesion and colonization

  Ross, B. N., Rojas-Lopez, M., Cieza, R. J., McWilliams, B. D. & Torres, A. G., Oct 30 2015, In: PloS one. 10, 10, e0141845.

  Research output: Contribution to journal › Article › peer-review

  • Escherichia coli O104
  • Shiga Toxin
  • Shiga-Toxigenic Escherichia coli
  • Shiga toxin-producing Escherichia coli
  • Escherichia coli
  19 Scopus citations

• Use of reverse vaccinology in the design and construction of nanoglycoconjugate vaccines against burkholderia pseudomallei

  Muruato, L. A., Tapia, D., Hatcher, C. L., Kalita, M., Brett, P. J., Gregory, A. E., Samuel, J. E., Titball, R. W. & Torres, A., Jan 1 2017, In: Journal fur Kardiologie. 24, 11-12, p. 280-284 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Vaccinology
  • Burkholderia pseudomallei
  • Glycoconjugates
  • Vaccines
  • Melioidosis

• Use of reverse vaccinology in the design and construction of nanoglycoconjugate vaccines against burkholderia pseudomallei

  Muruato, L. A., Tapia, D., Hatcher, C. L., Kalita, M., Brett, P. J., Gregory, A. E., Samuel, J. E., Titball, R. W. & Torres, A. G., Nov 2017, In: Clinical and Vaccine Immunology. 24, 11, e00206-17.

  Research output: Contribution to journal › Article › peer-review

  • Vaccinology
  • Burkholderia pseudomallei
  • Glycoconjugates
  • Vaccines
  • Animals
  20 Scopus citations

• Vacunas contra el SARS-CoV-2: ¿son una realidad para América Latina?

  Torres, A. G., 2020, In: Biomedica. 40, 3, p. 424-426 3 p.

  Research output: Contribution to journal › Editorial › peer-review